搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
10 小时
首款!FDA批准创新小分子药物上市
IterumTherapeutics今日宣布,美国FDA已批准其药品Orlynvah(sulopenem etzadroxil & ...
19 小时
FDA批准新型口服抗生素ORLYNVAH用于治疗非复杂性尿路感染
都柏林和芝加哥 - Iterum Therapeutics plc (NASDAQ:ITRM) 今天宣布,美国食品和药物管理局(FDA)已批准其新药申请ORLYNVAH™(sulopenem etzadroxil和probenecid)。该药物适用于治疗成年女性的非复杂性尿路感染(uUTIs),特别是由大肠杆菌、肺炎克雷伯菌或奇异变形杆菌引起的感染。ORLYNVAH™是美国首个获批的口服青霉烯类抗 ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Grateful Dead bassist dies
DOJ reaches settlement
DNA tests identify skull
World's most valuable firm
PA registration fraud probe
Strike kills 3 journalists
Arlington incident report
Browns sue city of Cleveland
Recalls chicken products
Murder-for-hire plot arrest
Approves Iterum's treatment
Apology for past US policy
Announces layoffs, jet sales
Madigan corruption trial
Israel strikes back at Iran
ABC News icon Jarriel dies
New student loan relief plan
CO ballots to be reexamined
E. coli infections rise to 75
Phones hacked by China?
Dismissal of charge upheld
SC teen voting glitch
Jeffries pleads not guilty
Louisiana forces relocation
NASA astronaut hospitalized
VA voter roll purge blocked
Exonerated after 22 years
Hit w/ discrimination claims
Won't endorse candidates
Sentenced for Jan. 6 role
反馈